1335016-14-2

Basic information

• Product Name: 4-(2-cyclopropylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzene-1,3-diol
• Synonyms: 4-(2-cyclopropylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzene-1,3-diol
• CAS NO: 1335016-14-2
• Molecular Weight: 273.315
• Mol File: 1335016-14-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-(2-cyclopropylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzene-1,3-diol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-cyclopropylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzene-1,3-diol(1335016-14-2)
• EPA Substance Registry System: 4-(2-cyclopropylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzene-1,3-diol(1335016-14-2)

Safety Data

• Hazardous Substances Data: 1335016-14-2(Hazardous Substances Data)

Upstream product

• 57235-50-4 2-amino-5-cyclopropyl-1,3,4-thiadiazole 
• 2491-39-6 2-bromo-2',4'-dihydroxyoacetophenone 

Downstream Products

• 1335016-61-9 4-(5-bromo-2-cyclopropylimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzene-1,3-diol 
• 1335016-81-3 4-(2-cyclopropyl-5-thiocyanatoimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzene-1,3-diol 

Relevant articles and documents

Design, synthesis and evaluation of small molecule imidazo[2,1-b][1,3,4]thiadiazoles as inhibitors of transforming growth factor-β type-I receptor kinase (ALK5)

A new series of imidazo[2,1-b][1,3,4]thiadiazoles 5(a-g), 6(a-g), 9(a-i) and 12(a-h) were synthesized as transforming growth factor-β (TGF-β) type I receptor (also known as activin receptor-like kinase 5 or ALK5) inhibitors. These compounds were evaluated